The FLVCR1 Gene Ataxia Posterior Column with Retinitis Pigmentosa Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the FLVCR1 gene. These mutations are known to be associated with a rare, inherited neurological disorder that affects the posterior column of the spinal cord and the retina, leading to symptoms such as impaired coordination and balance (ataxia) and progressive vision loss due to retinitis pigmentosa. The test, priced at 4400 AED, involves analyzing the patient's DNA to detect any genetic abnormalities in the FLVCR1 gene, aiding in the accurate diagnosis of this condition. This information is crucial for understanding the prognosis, planning treatment strategies, and offering genetic counseling for affected families.
The MT-TV gene is associated with a rare genetic disorder characterized by a spectrum of neurological symptoms including ataxia (loss of control of body movements), progressive seizures, mental deterioration, and hearing loss. These symptoms result from mutations in the mitochondrial tRNA gene, MT-TV, which plays a crucial role in mitochondrial protein synthesis. Mitochondria are the powerhouses of the cell, and their dysfunction leads to a wide array of metabolic and neurological disorders.
To diagnose this condition, DNA Labs UAE offers a specialized genetic test that targets the MT-TV gene to identify mutations. The test is a critical tool for confirming the diagnosis in individuals presenting with the aforementioned symptoms and can also be used for carrier testing in family members. Early and accurate diagnosis is vital for managing the symptoms and improving the quality of life of affected individuals.
The cost of the MT-TV related genetic test at DNA Labs UAE is 4400 AED. This comprehensive testing service is conducted in a state-of-the-art laboratory setting by a team of experienced geneticists and laboratory technicians. The test results can provide essential information for the development of a personalized treatment plan and inform patients about the progression of the disease and any potential interventions that may be beneficial.
The RNF170 Gene Ataxia Sensory Type 1 Autosomal Dominant Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the RNF170 gene, which are associated with a rare form of ataxia known as Sensory Type 1 Autosomal Dominant Ataxia. This condition primarily affects the nervous system, leading to issues with movement, coordination, and sometimes sensory functions. The test is particularly crucial for individuals showing symptoms of the disorder or those with a family history of ataxia, as it can confirm the diagnosis and facilitate appropriate management and treatment strategies.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test ensures accuracy and reliability in results. The cost of the test is set at 4400 AED, reflecting the comprehensive analysis involved in identifying the genetic mutation responsible for the condition. By opting for this test, patients and their families can gain valuable insights into their genetic health, enabling informed decisions about their medical care and lifestyle adjustments to accommodate the condition. DNA Labs UAE employs state-of-the-art technology and follows stringent protocols to ensure the confidentiality and safety of the patient's genetic information.
The APTX gene ataxia-oculomotor apraxia type 1 genetic test is a specialized diagnostic procedure designed to identify mutations in the APTX gene, which are associated with ataxia-oculomotor apraxia type 1 (AOA1). AOA1 is a rare, autosomal recessive disorder characterized by cerebellar ataxia, oculomotor apraxia, neuropathy, and in some cases, cognitive impairment. The condition typically manifests in childhood or early adolescence and progresses gradually.
This genetic test is crucial for confirming the diagnosis of AOA1, enabling affected individuals to receive appropriate management and support. It involves analyzing the patient's DNA, extracted from a blood sample, to look for specific mutations in the APTX gene that are known to cause the disorder.
The test is available at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. The cost of the APTX gene ataxia-oculomotor apraxia type 1 genetic test is 4400 AED. This price may include the cost of the sample collection, genetic analysis, and the provision of a detailed report explaining the results. Patients considering this test are advised to discuss it with their healthcare provider to understand its benefits and limitations in the context of their individual health condition and family history.
The SETX Gene Ataxia-Oculomotor Apraxia Type 2 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the SETX gene. These mutations are responsible for causing Ataxia-Oculomotor Apraxia Type 2 (AOA2), a rare genetic disorder characterized by progressive cerebellar ataxia and oculomotor apraxia. Symptoms of AOA2 often manifest in late childhood or adolescence, leading to coordination problems, difficulty with eye movements, and neuropathy.
The test is particularly valuable for individuals showing symptoms of AOA2 or those with a family history of the disorder, as it provides critical insights into the genetic underpinnings of their condition. By analyzing a sample of the patient's DNA, the test can confirm the presence of SETX gene mutations, enabling accurate diagnosis and guiding treatment decisions.
At a cost of 4400 AED, the SETX Gene Ataxia-Oculomotor Apraxia Type 2 Genetic Test at DNA Labs UAE represents a significant investment in personal health and genetic understanding. It is an essential resource for patients and families seeking clarity on this rare condition, offering a pathway towards more personalized care and management strategies.
The PIK3R5 Gene Ataxia-Oculomotor Apraxia Type 3 Genetic Test is a specialized diagnostic tool designed to detect mutations in the PIK3R5 gene, which are associated with Ataxia-Oculomotor Apraxia Type 3 (AOA3). AOA3 is a rare genetic disorder characterized by a combination of ataxia (lack of muscle coordination) and oculomotor apraxia (difficulty in moving the eyes on command), among other symptoms. Early and accurate diagnosis through genetic testing can be crucial for managing the condition, enabling targeted interventions and counseling for affected individuals and their families.
This test is available at DNA Labs UAE, a leading facility in genetic diagnostics and research. The cost of the test is 4400 AED. DNA Labs UAE employs cutting-edge technology and methodologies to ensure accurate and reliable results. By opting for this test, patients and healthcare providers can gain valuable insights into the genetic underpinnings of AOA3, paving the way for personalized treatment plans and better understanding of the condition's progression and impact.
The PNKP Gene Ataxia-Oculomotor Apraxia Type 4 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the PNKP gene, which are associated with Ataxia-Oculomotor Apraxia Type 4 (AOA4). AOA4 is a rare neurological disorder characterized by a combination of ataxia, which affects coordination and balance, and oculomotor apraxia, which impairs eye movements. This condition may also present other neurological symptoms, making early and accurate diagnosis crucial for managing the disease.
The test involves analyzing the patient's DNA to detect specific genetic alterations in the PNKP gene, which plays a crucial role in DNA repair processes. Identifying mutations in this gene can confirm a diagnosis of AOA4, allowing for targeted treatment plans and genetic counseling for affected individuals and their families.
The cost of the PNKP Gene Ataxia-Oculomotor Apraxia Type 4 Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis necessary to detect the genetic markers indicative of AOA4, providing essential information for disease management and familial planning.
The ATM Gene Ataxia-Telangiectasia Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to detect mutations in the ATM gene, which are responsible for Ataxia-Telangiectasia (A-T), a rare, neurodegenerative, inherited disease. This condition is characterized by progressive loss of muscle control, immune system problems, and a high risk of cancer. The test plays a crucial role in the early identification and management of the disease, enabling healthcare providers to devise appropriate treatment and intervention strategies to improve the quality of life for affected individuals. The cost of the test is 4400 AED, reflecting the advanced technology and expertise required to accurately analyze and interpret the genetic information. Conducted in the state-of-the-art facilities of DNA Labs UAE, this genetic test is a critical step for families seeking to understand their genetic health and manage the implications of Ataxia-Telangiectasia.
The DRD4 Gene Attention Deficit-Hyperactivity Disorder (ADHD) Genetic Test is a specialized diagnostic assessment offered by DNA Labs UAE, designed to identify specific genetic markers associated with ADHD. This test focuses on the analysis of the DRD4 gene, which has been linked to the neurotransmitter dopamine's regulation in the brain—a key factor in attention and activity levels. Given the complex nature of ADHD, understanding genetic predispositions can provide valuable insights for personalized treatment strategies. The test is priced at 4400 AED and is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring accuracy and confidentiality. Through this genetic testing, individuals can gain a deeper understanding of their condition, empowering them and their healthcare providers to make informed decisions regarding their health and management plans.
The DRD5 Gene Attention Deficit-Hyperactivity Disorder (ADHD) Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify genetic variations in the DRD5 gene, which have been associated with ADHD. This gene plays a crucial role in the dopamine signaling pathway, which is significant in regulating attention, behavior, and cognitive processes. Variations in the DRD5 gene can influence an individual's risk of developing ADHD, making this test a valuable resource for individuals seeking a deeper understanding of their ADHD diagnosis or for those exploring the genetic basis of their symptoms.
Priced at 4400 AED, the test involves collecting a DNA sample, typically through a non-invasive method such as a saliva swab. The sample is then analyzed in the state-of-the-art facilities of DNA Labs UAE, employing advanced genetic sequencing technologies to detect specific genetic markers within the DRD5 gene that are linked to ADHD. The results of this test can provide crucial insights into the genetic component of ADHD, aiding healthcare providers in tailoring more effective treatment and management plans for individuals based on their unique genetic makeup. It's an investment in personalized healthcare, offering a pathway to understanding and managing ADHD with a genetic perspective.
